STAT3 mutations are generally found almost exclusively in CD8+ rather than CD4+ patients (5), and more specifically, CD8+ CD16+ CD56- T-LGL leukemia patients exhibit more STAT3 mutations (49). Here, NCAM1 is linked to T-cell large granular lymphocyte leukemia.